Osteoprotective properties of a combination of HDBA complex and vitamins D3 and B6 (Osteo-Vit D3)


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The use of a number of drugs (including antibiotics) is accompanied by a higher risk of fractures, by the development of inflammatory joint diseases, and malfunctions of the immune and hematopoietic systems. Therefore, it is relevant to take drugs that are able to neutralize the negative effects of various drugs on the locomotor system and to safely restore bone strength in people of different age groups. These properties are available in the Russian osteobiotic Osteo-Vit D3, the intake of which is recommended to be combined with antibiotic therapy. There is evidence that the drug is able to neutralize the negative effects of various agents on the locomotor system and to safely restore bone strength in patients of any age. It is also important that the action of Osteo-Vit D3 is based on the activation of the body's own reserves. The drug does not contain calcium, since it has long been established that fractures occur due to impaired metabolism of the mineral rather than its deficiency. The active ingredients of the osteobiotic Osteo-Vit D3, such as the HDBA organic complex (drone homogenate) that has a pronounced gonadotropic activity and stimulates endogenous testosterone, which contributes to hormonal balance restoration and collagen production; vitamin D3 that is able to set in motion the body's own calcium reserves to increase bone mineral density; and vitamin B6 that can lower plasma homocysteine levels. The synergistic activity of these substances restores the body's impaired metabolism of calcium, as well as its bone tissue retention. The protective effect of the osteobiotic also extends to the immune and hematopoietic systems. Osteo-Vit D3 positively affects the mechanisms of both innate and acquired immunity, supporting the normal functioning of the immune system, and improves hematopoiesis. If antibiotic therapy cannot be avoided, the osteobiotic will protect organs and tissues from this therapy and reduce the number of adverse reactions.

Full Text

Restricted Access

About the authors

Irina Alexandrovna Samylina

I.M. SechenovFirst Moscow State Medical University (Sechenov University)

Email: laznata@mail.ru

Villory Ivanovich Strukov

Penza Institute for Postgraduate Training for Physicians, Branch, Russian Medical Academy of Continuing Professional Education

Email: villor3737@yandex.ru

Elena Vladimirovna Petrova

Penza State University

Email: petrovaelena2010@yandex.ru

Pavel Vladimirovich Poluboyarinov

Penza State University of Architecture and Construction

Email: 79502304876@yandex.ru

Natalia Viacheslavovna Eremina

Penza Institute for Postgraduate Training for Physicians, Branch, Russian Medical Academy of Continuing Professional Education

Email: ereminanat@gmail.com

Aleksandr Viktorovich Kotovsky

Penza Institute for Postgraduate Training for Physicians, Branch, Russian Medical Academy of Continuing Professional Education

Email: kotovskij@list.ru

Ramziya Timurovna Galeeva

Penza Institute for Postgraduate Training for Physicians, Branch, Russian Medical Academy of Continuing Professional Education

Email: rtgaleeva@gmail.com

Larisa Grigorievna Radchenko

Penza Institute for Postgraduate Training for Physicians, Branch, Russian Medical Academy of Continuing Professional Education

Email: lararad2012@yandex.ru

References

  1. Hathaway-Schrader J.D., Steinkamp H.M., Chavez M. B., Poulides N.A., Kirkpatrick J.E., Chew M. E., Huang E., Alekseyenko A.V., Aguirre J.I., Novince C. M. Antibiotic Perturbation of Gut Microbiota Dysregulates Osteoimmune Cross Talk in Postpubertal Skeletal Development. American Journal of Pathology. 2019. Vol. 189 (2): 370-90.
  2. Horton D. Antibiotics in Children Increase Risk for Juvenile Arthritis. URL : https://www.medscape.com/viewarticle/835110
  3. Yeh M.W., Zhou H., Adams A.L., Ituarte P.H., Li N., Liu I.L., Haigh P.I. The Relationship of Parathyroidectomy and Bisphosphonates With Fracture Risk in Primary Hyperparathyroidism: An Observational Study. Annals of Interna l Medicine. 2016. Vol. 164 (11): 715-23.
  4. Durham S., Miller R., Davis C., Shepler B. M. Bisphosphonate Nephrotoxicity Risks and Use in CKD Patients. US Pharmacist. 2010. Vol. 35 (5)
  5. Дадыкина И.С., Дадыкина П.С., Муравьев Ю.В. Основы изучения безопасности лекарственных средств. Спектр редких и неожиданных неблагоприятных реакций бисфосфонатов. Современная ревматология. 2011; 4: 79-86. [Dadykina I.S., Dadykina P.S., MuravievYu.V.Fundamentals of the study of the safety of medicinal plants. The spectrum of rare and unexpected adverse effects of bisphosphonates. Sovremennaya revmatologiya. 2011; 4: 79-86] (in Russian).
  6. Рожинская Л.Я. Диагностика и лечение остеопороза. Клиническая геронтология. 2007; 2: 37-46. [RozhinskayaL.Ya. Diagnostics and treatment of osteoporosis. Klinicheskaya gerontologiya. 2007; 2: 37-46] (in Russian).
  7. Sharma A., Chatterjee S., Arbab-Zadeh A., Goyal S., Lichstein E., Ghosh J., Aikat S. Risk of serious atrial fibrillation and stroke with use of bisphosphonates: evidence from a meta-analysis. Chest. 2013. Vol. 144 (4): 1311-22.
  8. Никитинская О. А., Торопцова Н. В., Беневоленская Л. И. Роль кальция и витамина Д в профилактике остеопороза и связанных с ним переломов. Медицинский совет. 2007; 2: 56-60. [Nikitinskaya O.A., Toroptsova N.V., Benevolenskaya L.I. The role of calcium and vitamin D in the prevention of osteoporosis and related fractures. Medicinskiy sovet. 2007; 2: 56-60] (in Russian).
  9. Bolland M. J., Avenell A., Baron J. A., Grey A., MacLennan G. S., Gamble G. D., Reid I. R. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: metaanalysis. British Medical Jornal. 2010. Vol. 341: 3691.
  10. Curhan G. C., Willett W.C., Speizer F.E., Spiegelman D, Stampfer M. J. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Annals of Internal Medicine. 1997. Vol. 126: 497-504.
  11. Baker M.J., Longyhore D.S. Dietary calcium, calcium supplements, and the risk of calcium oxalate kidney stones. American Journal of Health-System Pharmacy. 2006. Vol. 63 (8): 772-5.
  12. Jackson R.D., LaCroix A.Z., Gass M., Wallace R. B., Robbins J., Lewis C.E., Bassford T., Beresford S.A. et. al. Calcium plus vitamin D supplementation and the risk of fractures. New England Journal of Medicine. 2006. Vol. 354 (7): 66983.
  13. Bolland M.J., Barber P.A., Doughty R.N., Mason B., Horne A., Ames R., Gamble G. D., Grey A., Reid I. R. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. British Medical Journal. 2008. Vol. 336: 262-6.
  14. Ahn J., Albanes D., Peters U., Schatzkin A., Lim U., Freedman M., Chatterjee N., Andriole G. L., Leitzmann M. F., Hayes R. B. Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2007. Vol. 16 (12): 2623-30.
  15. Peggy E. Link Between Dietary Calcium and Prostate Cancer Risk Becomes More Complex. Oncology Times. 2006. Vol. 28 (18): 36, 37.
  16. Straub D. A. Calcium supplementation in clinical practice: a review of forms, doses, and indications. Nutrition in Clinica l Practice. 2007. Vol. 22 (3): 286-96
  17. Венчиков А. И. Биотики: к теории и практике применения микроэлементов. 2-е изд., перераб. и доп. Ашхабад : Ылым, 1978: 279 с. [Venchikov A.I. Biotics: the theory and practice of the use of microelements. 2nded., revisedanden-larged. Ashkhabad: Ylym, 1978. 279 p.] (in Russian).
  18. Tok E. C., Ertunc D., Oz U., Camdeviren H., Ozdemir G., Dilek S. The effect of circulating androgens on bone mineral den-city in postmenopausal women. Maturitas. 2004. Vol. 48 (3): 35-242.
  19. Davis S.R., McCloud P., Strauss B.J., Burger H. Testosterone enhances estradiols effects on postmenopausal bone density and sexuality. Maturitas. 2008. Vol. 61: 17-26.
  20. Dolan S.E., Carpenter S., Grinspoon S. Effects of weight, body composition, and testosterone on bone mineral density in HIV-infected women. Journal of AIDS. 2007. Vol. 45 (2): 161-7.
  21. Buchanan J. R., Hospodar P., Myers C., Leuenberger P., Demers L.M. Effect of excess endogenous androgens on bone density in young women. Journal of Clinical Endocrinology and Metabolism. 1988. Vol. 67 (5): 937-43.
  22. Бурмистрова Л.А. Физико-химический анализ и биохимическая оценка биологической активности трутневого расплода. Диссертация на соискание ученой степени кандидата биологических наук: 03.00.04. Рязань, 1999; 172 с. [Burmistrova L.A. Physicochemical analysis and biochemical evaluation of drone brood biological activity: thesis for the degree of candidate of biological sciences: 03.00.04. - Ryazan, 1999. - 172 p. (in Russian) ]
  23. Струков В. И., Джонс О., Крутяков Е. Н., Елистратов К. Г. Способ и препарат для профилактики и лечения атипичного остеопороза с нормальной или повышенной минерализацией костной ткани с наличием полостных образований в трабекулярных отделах костей (и ему близких состояниях при избыточной массе и метаболическом синдроме) : патент на изобретение RU 2497533. - 2013. URL: http://www.freepatent.ru/images/patents/495/2497533/patent-2497533.pdf
  24. Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. -Washington, DC: National Academy Press, 2010.
  25. Holick M. F., Garabedian M. Vitamin D: photobiology, metabolism, mechanism of action, and clinical applications. Primer on the metabolic bone diseases and disorders of mineral metabolism. 6th ed. ed. Favus M. J. Washington, DC: American Society for Bone and Mineral Research, 2006: 129-37.
  26. Bouillon R. Vitamin D: from photosynthesis, metabolism, and action to clinical applications. Endocrinology. eds. DeGroot L. J., Jameson J. L. Philadelphia : W.B. Saunders, 2001: 1009-28.
  27. DeLuca H.F. Overview of general physiologic features and functions of vitamin D. American Journal of Clinical Nutrition. 2004. Vol. 80: 1689-96.
  28. Heaney R.P., Dowell M.S., Hale C.A., Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. Journal оf the American College of Nutrition. 2003. Vol. 22: 142-6.
  29. Струков В.И., Болохонова Г.А. Причины гипервитаминоза D у детей. Здравоохранение Казахстана. 1972; 10. [Strukov V.I., Balakhonova G.A. Causes of hypervitaminosis D in children. Zdravoohranenie Kazahstana 1972; 10 (in Russian)].
  30. Boyan B. D., Hyzy S. L., Pan Q., Scott K. M. , Coutts R. D. , Healey R., Schwartz Z. 24R,25-Dihydroxyvitamin D3 Protects against Articular Cartilage Damage following Anterior Cruciate Ligament Transection in Male Rats. PLoS One. 2016. Vol. 11 (8).
  31. Dankers W., Colin E. M., van Hamburg J. P., Lubberts E. Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential. Frontiers in Immunology. 2016. Vol. 7: 697
  32. Masse P.G., Pritzker K., Mendes M.G., Boskey A.L. Vitamin B6 deficiency experimentally-induced bone and joint disorder: Microscopic, radiographic and biochemical evidence. British Journal of Nutrition. 1994. Vol. 71 (6): 919-32.
  33. Rondanelli M., Opizzi A., Perna S., Faliva M. A. Update on nutrients involved in maintaining healthy bone. Endocrinologia y Nutricion. 2013. Vol. 60: 197-210.
  34. Громова О. А., Торшин И. Ю., Лиманова О. А. Кальций и его синергисты в поддержке структуры соединительной и костной ткани. Лечащий врач. 2014; 5: 2-7. [Gromova O. A., Torshin I. Yu., Limanova O. A. Calcium and its synergists to support the structure of connective and bone tissue. Lechashhiy vrach. 2014; 5: 2-7 (in Russian)].
  35. Holstein J. H., Herrmann M., Splett C., Herrmann W., Garcia P., Histing T. Low serum folate and vitamin B-6 are associated with an altered cancellous bone structure in humans. American Journal of Clinical Nutrition. 2009. Vol. 90: 1440-5.
  36. McLean R.R., Jacques P.F., Selhub J. Plasma B Vitamins, Homocysteine, and their relation with bone loss and hip fracture in elderly men and women. Journal of Clinical Endocrinology and Metabolism. 2008. Vol. 93: 2206-12.
  37. Feskanich D., Willett W. C., Stampfer M. J., Colditz G. A. Milk, dietary calcium, and bone fractures in women: a 12-year prospective study. American Journal of Public Health. 1997. Vol. 87 (6): 992-7.
  38. Owusu W., Willett W. C., Feskanich D., Ascherio A., Spiegelman D., Colditz G. A. Calcium intake and the incidence of forearm and hip fractures among men. Journal of Nutrition. 1997. Vol. 127 (9): 1782-7.
  39. Струков В.И., Елистратов Д.Г., Щербакова Ю.Г., Купцова Т.А., Галеева Р.Т., Радченко Л.Г., Максимова М.Н. «Остео-Вит D3» в лечении и профилактике повторных переломов у детей с низкой минеральной плотностью костной ткани. Медицинская сестра. 2014; 7: 44-6. [Strukov V.I., Elistratov D.G., Shherbakova Yu.G., Kuptsova T.A., Galeeva R.T., Radchenko L.G., Maksimova M.N. «Osteo-Vit D3» in treatment and prevention of repeated fractures in children having low bone mineral density. Meditsinskaya sestra. 2014; 7: 44-6 (in Russian)].
  40. Купцова Т.А. , Василистов Д.Б. , Агафонов Д.В. Проблема отрывных переломов у спортсменов-подростков на клиническом примере. Теория и практика создания тренажеров: накопление и обработка информации, информационные модели, средства информатизации. Материалы международной конференции, вып. 1. Пенза: Пензенский государственный технологический университет, 2015: 102-5. [Kuptsova T.A., Vasilistov D.B., Agafonov D.V. The problem of avulsion fractures in adolescent athletes based on a clinical example. Theory and practice of creating simulators: information accumulation and processing, information models, means of informatization: proceedings of the international conference, issue 1. Penza: Penza State Technological University, 2015: 102-5 (in Russian)].
  41. Поликарпочкин А.Н., Левшин И.В., Вовк Е.В., Струков В.И., Раскачкин В.А., Токарев А.В. Оценка эффективности применения гипербарической оксигенации и препарата «Остео-Вит D3» при лечении гонартрозов. Гипербарическая физиология и медицина. 2018; 1: 13-24. [Polikarpochkin A.N., Levshin I.V., Vovk E.V., Strukov V.I., Raskachkin V.A., Tokarev A.V. Evaluation of the effectiveness of hyperbaric oxygenation and preparation «Osteo-Vit D3» in the treatment of gonarthrosis. Giperbaricheskaya fiziologiya i meditsina. 2018; 1: 13-24 (in Russian)].
  42. Пигарова Е.А., Плещева А.В., Дзеранова Л.К. Влияние витамина D на иммунную систему. Иммунология. 2015; 1: 62-6. [Pigarova E.A., Pleshheva A.V., Dzeranova L.K. Vitamin D influence on the immune system. Immunologiya. 2015; 1: 62-6 (in Russian)].
  43. Абатуров А.Е., Завгородняя Н.Ю. Витамин-D-зависимая продукция антимикробных пептидов. Клiнiчнi лекцiї. 2012; 1 (36): 105-111
  44. Клишина И. И. Влияние трутневого расплода на активность факторов неспецифической резистенции и функциональное состояние печени при острой интоксикации. Диссертация на соискание ученой степени кандидата фармацевтических наук : 14.00.25. Пятигорская государственная фармацевтическая академия. Пятигорск, 2003. [Klishina I.I. Drone brood influence on the activity of nonspecific resistance factors and liver functional state in case of acute intoxication: thesis for the degree of candidate of pharmaceutical sciences: 14.00.25. Pyatigorsk State Pharmaceutical Academy. Pyatigorsk, 2003 (in Russian)].
  45. Leklem J.E. Vitamin B6. Modern Nutrition in Health and Disease. eds. Shils M., Olson J.A., Shike M., Ross A.C. 9th ed. Baltimore : Williams & Wilkins, 1999: 413-22.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2020 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies